ATR vs CLOV · P/E 21, rev $3.58B vs rev $1.37B
AptarGroup Inc (ATR) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
AptarGroup Inc (ATR) is a medical instruments & supplies company listed on NYSE.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ATR revenue for 2024-12-31 was $3.58B. Net income was $374.2M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. ATR currently screens at market cap $7.66B and trailing P/E 20.5.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ATR currently screens at market cap $7.66B and trailing P/E 20.5. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ATR and CLOV stock pages for the full models.
Not investment advice.